MedTrace Logo

UCP Glaucoma Treatment for Primary Glaucoma in China

NCT04145830 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2021-08-19

No results posted yet for this study

Summary

To collect safety and efficacy data on Ultrasound Cycle Plasty treatment (UCP) in primary glaucoma asian patients.

Conditions

  • Glaucoma Treatment Using Focused Ultrasound

Interventions

DEVICE

Ultrasound Cyclo Plasty (UCP)

Cyclocoagulation using High Intensity Focused Ultrasound

Sponsors & Collaborators

  • EyeTechCare

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-09-01
Primary Completion
2020-04-29
Completion
2020-11-02

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04145830 on ClinicalTrials.gov